tradingkey.logo

Vivos Therapeutics Inc

VVOS

4.970USD

-0.210-4.05%
Market hours ETQuotes delayed by 15 min
29.27MMarket Cap
LossP/E TTM

Vivos Therapeutics Inc

4.970

-0.210-4.05%
More Details of Vivos Therapeutics Inc Company
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
Company Info
Ticker SymbolVVOS
Company nameVivos Therapeutics Inc
IPO dateDec 11, 2020
CEOMr. R. Kirk Huntsman
Number of employees109
Security typeOrdinary Share
Fiscal year-endDec 11
Address7921 Southpark Plaza,
CityLITTLETON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80120
Phone18669084867
Websitehttps://vivos.com/
Ticker SymbolVVOS
IPO dateDec 11, 2020
CEOMr. R. Kirk Huntsman
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. Sokolow, CPA
Mr. Leonard J. Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. Sokolow, CPA
Mr. Leonard J. Sokolow, CPA
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Appliance sales to integrated providers
1.27M
42.21%
Center revenue
540.00K
17.90%
Sponsorship/seminar
328.00K
10.88%
VIP
223.00K
7.39%
Billing intelligence service
181.00K
6.00%
Other
471.00K
15.62%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Appliance sales to integrated providers
1.27M
42.21%
Center revenue
540.00K
17.90%
Sponsorship/seminar
328.00K
10.88%
VIP
223.00K
7.39%
Billing intelligence service
181.00K
6.00%
Other
471.00K
15.62%
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Skaff (Michael C.)
12.33%
Luo (Dawei)
8.52%
V-CO Investors, L.L.C.
7.66%
Armistice Capital LLC
3.73%
Intracoastal Capital, L.L.C.
3.40%
Other
64.37%
Shareholders
Shareholders
Proportion
Skaff (Michael C.)
12.33%
Luo (Dawei)
8.52%
V-CO Investors, L.L.C.
7.66%
Armistice Capital LLC
3.73%
Intracoastal Capital, L.L.C.
3.40%
Other
64.37%
Shareholder Types
Shareholders
Proportion
Individual Investor
21.93%
Corporation
11.06%
Hedge Fund
3.73%
Investment Advisor
2.51%
Investment Advisor/Hedge Fund
1.31%
Venture Capital
1.24%
Research Firm
0.27%
Bank and Trust
0.04%
Other
57.92%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
60
2.25M
33.57%
+1.04M
2025Q1
65
1.44M
22.49%
+733.38K
2024Q4
63
1.28M
22.00%
+869.59K
2024Q3
68
786.28K
18.32%
+305.75K
2024Q2
66
387.48K
12.85%
-179.65K
2024Q1
67
465.07K
19.33%
-62.17K
2023Q4
69
458.43K
25.00%
-105.78K
2023Q3
76
380.33K
31.77%
-57.99K
2023Q2
78
390.56K
32.63%
-94.20K
2023Q1
75
401.83K
33.57%
+53.80K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Skaff (Michael C.)
828.00K
12.33%
+828.00K
--
Jun 09, 2025
V-CO Investors, L.L.C.
514.50K
7.66%
--
--
Jun 09, 2025
Armistice Capital LLC
250.28K
3.73%
+250.28K
--
Sep 30, 2024
Intracoastal Capital, L.L.C.
228.61K
3.4%
+228.61K
--
Dec 30, 2024
Ionic Ventures LLC
83.00K
1.24%
+83.00K
--
Sep 30, 2024
Huntsman (Ronald Kirk)
73.06K
1.09%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
57.35K
0.85%
+12.52K
+27.93%
Mar 31, 2025
Cutter & Company, Inc.
49.10K
0.73%
+11.00K
+28.87%
Mar 31, 2025
The Vanguard Group, Inc.
42.63K
0.63%
+32.05K
+303.01%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
DFA Dimensional US Sustainability Core 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 26, 2023
Merger
25<1
Oct 26, 2023
Merger
25<1
Oct 26, 2023
Merger
25<1
Oct 26, 2023
Merger
25<1
Date
Type
Ratio
Oct 26, 2023
Merger
25<1
Oct 26, 2023
Merger
25<1
Oct 26, 2023
Merger
25<1
Oct 26, 2023
Merger
25<1
KeyAI